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Small Animals
Septic peritonitis is associated with a high mortality rate, and it is a major cause of sepsis in dogs. The 
most common predisposing cause for septic peritoni-
tis is the contamination of (or translocation into) the 
peritoneal cavity by microorganisms normally pres-
ent in abdominal organs.1,2 Endotoxins produced by 
bacteria cause the release of inflammatory cytokines, 
including interleukin, tumor necrosis factor, and pros-
tanoids, which contribute to vasomotor paralysis and 
capillary occlusion with secondary leakage of fluid 
into the interstitium.3–7 The clinical signs of septic 
peritonitis may be vague, but distributive shock fre-
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OBJECTIVE
To investigate whether intraoperative administration of a lidocaine infusion 





75 dogs with septic peritonitis.
PROCEDURES
Medical records of dogs with septic peritonitis that underwent laparotomy 
between January 2007 and December 2011 at the Royal Veterinary College 
were reviewed. Select variables during the preoperative, intraoperative, and 
postoperative periods and short-term survival after surgery were compared 
between dogs that received an opioid only (group O; n = 33) and dogs that 
received lidocaine (50 µg/kg/min [22.7 µg/kg/min], IV; group L; 42) in addition 
to an opioid during surgery.
RESULTS
The proportion of dogs that survived for 48 hours after surgery was signifi-
cantly greater for group L (35/42) than for group O (20/33). Intraoperative 
infusion of lidocaine increased the odds of short-term survival (OR, 8.77; 
95% CI, 1.94 to 39.57). No significant differences were observed between 
the 2 treatment groups for variables assessed during the preoperative and 
postoperative periods. During the intraoperative period, more dogs in group 
L received an IV bolus of a synthetic colloid than did dogs in group O, but 
the number of IV boluses administered was not associated with short-term 
survival.
CONCLUSIONS AND CLINICAL RELEVANCE
Results indicated that IV infusion of lidocaine might improve the short-term 
survival of dogs with septic peritonitis. Prospective clinical trials are necessary 
to determine the efficacy of lidocaine as a supportive treatment for dogs with 
septic peritonitis. (J Am Vet Med Assoc 2016;248:422–429)
quently develops and is characterized by tachycardia, 
hypotension, and a decrease in systemic vascular resis-
tance subsequent to the inflammatory response.3,5–10 
Dogs with septic peritonitis may require anesthesia 
for diagnostic procedures or surgery, and they are gen-
erally poor anesthesia candidates because their hemo-
dynamic stability is often compromised.
Lidocaine possesses analgesic and inflammatory 
modulator properties and is commonly used as a local 
anesthetic.4–6,11 Intravenous infusion of lidocaine (33 
to 50 µg/kg/min [15.0 to 22.7 µg/lb/min]) substan-
tially diminishes the production of inflammatory cy-
tokines in rats,3 rabbits,6 and horses4 with experimen-
tally induced endotoxemia and attenuates leukocyte 
adhesion to the endothelium of mice when it is in-
fused before or immediately after IV administration of 
endotoxin.5 In mice5 and dogs7 with experimentally 
induced sepsis, IV infusion of lidocaine decreases the 
ABBREVIATIONS
ASA  American Society of Anesthesiologists
CI  Confidence interval
CRI  Constant rate infusion
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mortality rate despite having no observable beneficial 
effects on systemic hemodynamics.
Few studies7,8 have been conducted to investigate 
the effects of IV infusion of lidocaine in dogs with 
experimentally induced septicemia. The purpose of 
the study reported here was to investigate whether 
intraoperative administration of a lidocaine infusion to 
dogs with septic peritonitis was associated with sur-
vival within 48 hours after surgery.
Materials and Methods
Case selection
The medical record database for the Royal Veteri-
nary College was searched between January 2007 and 
December 2011 to identify the records of dogs that con-
tained the terms sepsis or peritonitis. Dogs were consid-
ered for study inclusion if they underwent a laparotomy 
and septic peritonitis was confirmed on the basis of iden-
tification of intracellular bacteria during cytologic evalu-
ation or bacterial growth during bacteriologic culture 
of abdominal effusion fluid. Dogs were also considered 
for study inclusion if a perforation of the gastrointesti-
nal or uterine wall was identified during an exploratory 
laparotomy. The anesthesia and intensive care records 
for those dogs were examined. The care of all dogs was 
managed by residents who were supervised by senior 
clinicians, and the use of an intraoperative lidocaine infu-
sion was at the discretion of the attending anesthetist. 
Only dogs that received an opioid alone (group O) or 
an opioid plus lidocaine (2 mg/kg [0.9 mg/lb], IV bolus, 
followed by a CRI of 50 µg/kg/min; group L) during sur-
gery were included in the study. Excluded from the study 
were dogs that underwent a laparotomy to diagnose or 
treat septic peritonitis within 48 hours prior to the sur-
gery of interest, received lidocaine prior to surgery, re-
ceived a loading dose or CRI of lidocaine different from 
that specified for study inclusion, or received multiple 
lidocaine IV boluses during the intraoperative and post-
operative period.
Medical records review
For each dog included in the study, information 
extracted from the medical record included age, 
sex, weight, source of infection, clinical examination 
findings, source of peritonitis, ASA status, types and 
amounts of fluids and medications administered, and 
outcome at 48 hours after surgery.
Data analysis
Dogs were separated into 2 treatment groups on the 
basis of whether they received an opioid only (group 
O) or an opioid plus lidocaine (group L) during surgery. 
The data for each dog were separated into 3 time peri-
ods (preoperative, intraoperative, and postoperative) for 
analysis. Variables of interest for the preoperative period 
included heart rate, respiratory rate, body temperature, 
type of IV fluids administered before surgery, and time 
from hospital admission to induction of anesthesia (not 
evaluated for dogs that developed septic peritonitis as 
a result of complications from a previous surgery dur-
ing the same hospitalization). Variables of interest for the 
intraoperative period included ASA status immediately 
before anesthesia, types of anesthetic agents used, type 
of opioid administered, type and amounts of IV fluids 
administered, number of IV fluid boluses administered, 
number of dogs that received vasopressors and inotropes 
to support hemodynamic function, heart rate, duration 
of hypotension (systolic arterial pressure < 90 mm Hg or 
mean arterial pressure < 60 mm Hg for > 10 minutes), 
body temperature at extubation, and anesthesia duration. 
The postoperative period was defined as the 48 hours 
immediately after surgery. Variables of interest in the 
postoperative period included types of drugs used for 
analgesia, number of dogs that received a lidocaine infu-
sion after surgery, type and amount of IV fluids admin-
istered, and number of dogs that received vasopressors 
and inotropes to support the cardiovascular system.
Within each period, variables of interest were com-
pared between the 2 treatment groups. The data distribu-
tions for continuous variables were assessed for normality 
by use of the Kolmogorov-Smirnov test. For continuous 
variables that were normally distributed, comparisons 
between treatment groups were performed with inde-
pendent Student t tests. For continuous variables that 
were not normally distributed, comparisons between 
treatment groups were performed with Mann-Whitney 
U tests. For categorical variables, the frequency distribu-
tions were reported as proportions and either a χ2 test 
or Fisher exact test (for outcomes in which the number 
of dogs within at least 1 cell was ≤ 5) was performed to 
compare differences between the 2 treatment groups. 
The outcome at 48 hours after surgery (alive or dead) 
was compared between the 2 treatment groups by 
means of a χ2 test. When the study population was 
stratified by ASA status immediately prior to anesthesia, 
the outcome at 48 hours after surgery was compared 
between the treatment groups within each stratum by 
use of a Fisher exact test. For all comparisons between 
treatment groups, values of P < 0.05 were considered 
significant.
Logistic regression analysis was used to evaluate 
the association between each of the variables of inter-
est for all periods and the probability that a dog was 
alive 48 hours after surgery. Univariate models were 
evaluated initially, and variables with values of P < 0.10 
on univariate analysis were eligible for inclusion in a 
multivariable model.  A multivariable model was con-
structed by stepwise backward selection, and only vari-
ables with P < 0.05 were retained in the final model.  A 
Hosmer-Lemeshow test was used to assess how well 
the final multivariable model fit the data. The OR and 
associated 95% CI for each variable retained in the final 
model were reported.  All analyses were performed with 
a commercially available statistical software package.a
Results
Dogs
Seventy-five dogs met the inclusion criteria and 
were enrolled in the study. Group O (dogs that did 
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not receive lidocaine during surgery) consisted of 33 
dogs and included 9 (27.3%) females and 24 males 
(72.7%; neuter status not reported for any dogs in the 
study) with a median age of 48 months (range, 3 to 
142 months). Group L (dogs that received a CRI of 
lidocaine during surgery) consisted of 42 dogs and in-
cluded 12 (28.6%) females and 30 (71.4%) males with 
a median age of 60 months (range, 5 to 126 months). 
The median age (P = 0.304) and sex distribution (P 
= 1.000) did not differ significantly between the 2 
treatment groups. Body weight was categorized into 
3 categories (< 10 kg [22 lb], 10 to 20 kg [22 to 44 
lb], and > 20 kg). Of the 33 dogs in group O, 7 (21.2%) 
weighed < 10 kg, 6 (18.2%) weighed between 10 and 
20 kg, and 20 (60.6%) weighed > 20 kg. Of the 42 dogs 
in group L, 7 (16.7%) weighed < 10 kg, 11 (26.2%) 
weighed between 10 and 20 kg, and 24 (57.1%) 
weighed > 20 kg. The frequency distribution of dogs 
among the 3 weight categories did not differ signifi-
cantly (P = 0.526) between the treatment groups. 
Within group O, the source of peritonitis was classi-
fied as gastrointestinal for 25 (75.8%) dogs, hepatobili-
ary for 2 (6.1%) dogs, urogenital for 1 (3.0%) dog, and 
other for 5 (15.2%) dogs. Within group L, the source of 
the peritonitis was classified as gastrointestinal for 33 
(78.6%) dogs, hepatobiliary for 1 (2.4%) dog, urogeni-
tal for 3 (7.1%) dogs, and other for 5 (11.9%) dogs. The 
frequency distribution of dogs among the 4 categories 
for peritonitis source did not differ significantly (P = 
0.738) between the treatment groups.
Outcome Group O Group L P value
Heart rate (beats/min) 120 (50–200) 120 (60–188) 0.953
Respiratory rate (breaths/min)* 33 ± 14 34 ± 14 0.931
Body temperature (°C)† 38.5 (35.7–40.1) 38.1 (34.8–40.4) 0.250
Received IV infusion of
  lactated Ringer solution  —  — 0.338
    Yes 20 (60.6) 30 (71.4)                         —
    No 13 (39.4) 12 (28.6)                         —
No. of IV boluses (5 mL/kg) of 
  lactated Ringer solution received  —  — 0.790
    0 21 (63.6%) 23 (54.8%)                      —
    1 8 (24.2%) 15 (35.7%)                      —
    2 3 (9.1%) 3 (7.1%)                        —
    3 1 (3.0%) 1 (2.4%)                        —
Received IV infusion of a synthetic 
   colloid (6% hydroxyethyl starch  —  — 0.395
   in saline [0.9% NaCl] solution) solution
   Yes 9 (27.3%) 7 (16.7%)                      —
     No 24 (72.7%) 35 (83.3%)                      —
No. of IV boluses (1–2 mL/kg) of 
   synthetic colloid fluids received  —  — 0.949
     0 26 (78.8%) 31 (73.8%)                      —
     1 5 (15.2%) 6 (14.3%)                      —
     2 1 (3.0%) 3 (7.1%)                        —
     3 0 (0.0%) 1 (2.4%)                        —
     4 1 (3.0%) 1 (2.4%)                        —
Received IV infusion of a blood product  —  — 1.000
    Yes 1 (3.0%) 2 (4.8%)                        —
    No 32 (97.0%) 40 (95.2%)                      —
Time from hospital admission to anesthesia‡  —  — 0.361
    ≤ 24 h 28 (87.5%) 31 (77.5%)                      —
    > 24 h 4 (12.5%) 9 (22.5%)                      —
Values for the treatment groups represent the median (range), mean ± SD, or number (%) of dogs. 
*Respiratory rate was recorded for only 29 dogs in group O and 37 dogs in group L. †Body temperature was 
recorded for only 31 dogs in group O and 40 dogs in group L. ‡The time from hospital admission to anesthesia 
was available for only 32 dogs in group O and 40 dogs in group L. 
— = Not applicable.
To convert mL/kg to mL/lb, divide by 2.2.
Table 1—Descriptive data for the outcomes of interest during the preoperative period for 75 dogs 
with septic peritonitis that did (group L; n = 42) and did not (group O; 33) receive an IV infusion of 
lidocaine (2 mg/kg [0.9 mg/lb], IV bolus, followed by a CRI of 50 µg/kg/min [22.7 µg/kg/min]) during 
laparotomy.
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Outcome Group O Group L P value
ASA status  —  — 0.840
    III 4 (12.1%) 4 (9.5%)                        —
    IV 17 (51.4%) 22 (57.1%)                      —
    V 12 (36.4%) 16 (33.3%)                      —
Anesthesia induction agent used  —  — 0.952
    Propofol 6 (18.2%) 7 (16.7%)                      —
    Alfaxalone 11 (33.3%) 13 (31.0%)                      —
    Fentanyl and midazolam 16 (48.5%) 22 (52.4%)                      —
Anesthesia maintenance agent used  —  — 0.499
    Isoflurane 33 (100%) 40 (95.2%)                      —
    Sevoflurane 0 (0%) 2 (4.8%)                        —
Intraoperative opioid administered  —  — 0.327
    Fentanyl 31 (93.9%) 37 (88.1%)                      —
    Methadone 2 (6.1%) 5 (11.9%)                      —
IV infusion rate for lactated Ringer solution  —  — 0.689
    ≤ 10 mL/kg/h 31 (93.9%) 38 (90.5%)                      —
    > 10 mL/kg/h 2 (6.1%) 4 (9.5%)                        —
No. of IV boluses (5 mL/kg) of 
    lactated Ringer solution received  —  — 0.488
      0 20 (60.6%) 22 (52.4%)                      —
      1 7 (21.2%) 11 (26.2%)                      —
      2 6 (18.2%) 6 (14.3%)                      —
      3 0 (0.0%) 3 (7.1%)                        —
Received IV infusion of a synthetic 
    colloid (6% hydroxyethyl starch   —  — 0.632
    in saline solution) solution
    Yes 11 (33.3%) 17 (40.5%)                      —
      No 22 (66.7%) 25 (59.5%)                      —
No. of IV boluses (1–2 mL/kg) of 
    synthetic colloid fluids received  —  — 0.024
      0 26 (78.8%) 20 (47.6%)                      —
      1 4 (12.1%) 9 (21.4%)                      —
      2 2 (6.1%) 8 (19.0%)                      —
      3 0 (0.0%) 4 (9.5%)                        —
      4 1 (3.0%) 0 (0.0%)                        —
      5 0 (0.0%) 1 (2.4%)                        —
Received IV infusion of a blood product  —  — 0.507
    Yes 7 (21.2%) 10 (23.8%)                      —
    No 26 (78.8%) 32 (76.2%)                      —
Received a vasopressor  —  — 0.207
    Yes 8 (24.2%) 15 (35.7%)                      —
    No 25 (75.8%) 27 (64.3%)                      —
Received an inotrope  —  — 0.459
    Yes 2 (6.1%) 7 (16.7%)                      —
    No 31 (93.9%) 35 (83.3%)                      —
Heart rate (beats/min)* 120 (70–177) 115 (70–200) 0.843
Duration of hypotension†  —  — 0.673
    ≤ 10 min 10 (31.3%) 10 (23.8%)                      —
    10–25 min 7 (21.9%) 8 (19.0%)                      —
    > 25 min 15 (46.9%) 24 (57.1%)                      —
Body temperature at extubation (°C)* 35.4 (34.1–38.4) 35.9 (33.1–38.2) 0.449
Anesthesia duration (min)* 185 (95–335) 210 (105–320) 0.202
Values for the treatment groups represent the median (range) or number (%) of dogs. 
*Information available for only 31 dogs in group O and 41 dogs in group L. †Information available for only 
32 dogs in group O and 42 dogs in group L. 
— = Not applicable. 
See Table 1 for remainder of key.
Table 2—Descriptive data for the outcomes of interest during the intraoperative period for the 
dogs of Table 1.
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Preoperative period
Descriptive data for the outcomes of interest dur-
ing the preoperative period were summarized (Table 
1). None of the outcomes assessed differed signifi-
cantly between the treatment groups. The majority of 
the dogs (59/75 [79%]) were anesthetized for surgery 
within 24 hours after hospital admission, and only 13 
(17%) dogs were anesthetized for surgery > 24 hours 
(range, 35 hours to 3 days) after hospital admission; 
the time from hospital admission to surgery was not 
reported for 3 (4%) dogs.
Intraoperative period
Descriptive data for the outcomes of interest 
during the intraoperative period were summarized 
(Table 2). None of the outcomes assessed differed sig-
nificantly between the treatment groups, except the 
number of IV boluses of synthetic colloid solution ad-
ministered; more dogs in group L received at least 1 
IV bolus of synthetic colloid during surgery than did 
dogs in group O (P = 0.024). The opioids most fre-
quently administered to dogs during surgery were 
fentanyl (0.1 to 0.3 µg/kg/min [0.045 to 0.136 µg/lb/
Outcome Group O Group L P value
Received opioid for analgesia  —  — 1.000
    Yes 31 (93.9%) 40 (95.2%)                     —
    No 2 (6.1%) 2 (4.8%)                       —
Received lidocaine for analgesia  —  — 0.123
    Yes 6 (18.2%) 15 (35.7%)                     —
    No 27 (81.8%) 27 (64.3%)                     —
Received IV infusion of lactated Ringer solution  —  — 0.579
    Yes 31 (93.9%) 41 (97.6%)                     —
    No 2 (6.1%) 1 (2.4%)                       —
No. of IV boluses (5 mL/kg) of 
  lactated Ringer solution received  —  — 0.201
    0 28 (84.8%) 28 (66.7%)                     —
    1 3 (9.1%) 6 (14.3%)                     —
    2 0 (0.0%) 1 (2.4%)                       —
    3 0 (0.0%) 4 (9.5%)                       —
    4 1 (3.0%) 3 (7.1%)                       —
    ≥ 5 1 (3.0%) 0 (0.0%)                       —
Received IV infusion of a synthetic   —  — 0.816
    colloid (6% hydroxyethyl starch in  
    saline solution) solution 
      Yes 14 (42.4%) 20 (47.6%)                     —
      No 19 (57.6%) 22 (52.4%)                     —
No. of IV boluses (1–2 mL/kg) of 
    synthetic colloid fluids received  —  — 0.949
      0 28 (84.8%) 31 (73.8%)                     —
      1 3 (9.1%) 3 (7.1%)                       —
      2 2 (6.1%) 2 (4.8%)                       —
      3 0 (0.0%) 3 (7.1%)                       —
      4 0 (0.0%) 2 (4.8%)                       —
       ≥ 5 0 (0.0%) 1 (2.4%)                       —
Received IV infusion of a blood product  —  — 1.000
    Yes 8 (24.2%) 10 (24.4%)                     —
    No 25 (75.8%) 31 (75.6%)                     —
Received a vasopressor*  —  — 1.000
    Yes 5 (15.2%) 7 (17.1%)                     —
    No 28 (84.8%) 34 (82.9%)                     —
Received an inotrope*  —  — 0.725
    Yes 3 (9.1%) 5 (12.2%)                     —
    No 30 (90.9%) 36 (87.8%)                     —
Values for the treatment groups represent the median (range) or number (%) of dogs. 
* Information available for only 41 dogs in group L. 
— = Not applicable. 
See Table 1 for remainder of key.
Table 3—Descriptive data for the outcomes of interest during the postoperative period for the 
dogs of Table 1.
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min], IV, CRI) and methadone (0.1 to 0.2 mg/kg [0.045 
to 0.091 mg/kg], IV, intermittently as needed). The me-
dian duration of anesthesia for dogs in group L was 
longer than that for the dogs of group O; however, that 
difference was not significant (P = 0.202).
Postoperative period
Descriptive data for the outcomes of interest dur-
ing the postoperative period were summarized (Table 
3). None of the variables assessed differed significantly 
between the treatment groups. The opioids most fre-
quently administered during the postoperative period 
were morphine, methadone, and fentanyl. Some dogs 
also received lidocaine (30 µg/kg/min [13.64 µg/lb/
min], CRI for 6 to 12 hours) for additional analgesia 
during the postoperative period.
Short-term survival after surgery
The proportion of dogs that remained alive at 48 
hours after surgery was significantly (P = 0.036) great-
er for group L (35/42 [83.3%]) than that for group O 
(20/33 [60.6%]). Of the 13 dogs from group O that did 
not survive, 6 died of cardiac arrest and 7 were eutha-
nized because of a deteriorating clinical condition. Of 
the 7 dogs from group L that did not survive, 3 died 
from cardiac arrest and 4 were euthanized because of 
a deteriorating clinical condition. When survival was 
assessed as a function of ASA status prior to surgery, all 
12 dogs in group O that were classified as ASA V prior 
to surgery died within 48 hours after surgery, whereas 
only 5 of 16 (31.3%) dogs in group L that were clas-
sified as ASA V prior to surgery died within that same 
period (P < 0.001). The proportion of dogs in group O 
that were classified as ASA IV (1/17 [5.9%]) or ASA III 
(0/4) prior to surgery and died within 48 hours after 
surgery did not differ significantly (P = 1.000) from 
the proportion of dogs in group L that were classified 
as ASA IV (2/22 [9.1%]) or ASA III (0/4) prior to sur-
gery and died within 48 hours after surgery.
Results of the multivariable logistic regression analy-
sis revealed that a CRI of lidocaine significantly increased 
the odds of survival at 48 hours after surgery (OR, 8.77; 
95% CI, 1.94 to 39.57; P = 0.005) when administered 
during the intraoperative period, but decreased the odds 
of survival at 48 hours after surgery (OR, 0.13; 95% CI, 
0.03 to 0.52; P = 0.004) when administered during the 
postoperative period. Although the number of synthetic 
colloid IV boluses (1 to 2 mL/kg [0.45 to 0.9 mL/lb] of 
6% hydroxyethyl starch in saline [0.9% NaCl] solution) 
administered appeared to decrease the odds of survival 
at 48 hours after surgery (OR, 0.71; 95% CI, 0.40 to 1.24), 
that association was not significant (P = 0.227).
Discussion
Results of the present study suggested that admin-
istration of lidocaine (2 mg/kg, IV bolus, followed by 
a CRI of 50 µg/kg/min) to dogs with septic peritoni-
tis during surgery significantly increased the odds for 
short-term (ie, 48 hours) survival of those dogs after sur-
gery. This finding supported the results of other studies 
that indicate intraoperative administration of lidocaine 
has analgesic, anti-inflammatory, and anti-endotoxin ef-
fects in horses,4 mice,5 rabbits,6 and dogs.11
The survival rate for dogs with septic peritonitis 
ranges from 50% to 80%.1,12 In individuals with sep-
sis, death is caused by dysfunction of multiple organ 
systems, and the likelihood of death increases as the 
number of dysfunctional organ systems increases.2 In 
1 study,5 renal and hepatic functions were improved 
and the mortality rate was decreased for mice with ex-
perimentally induced septic peritonitis that received a 
CRI of lidocaine, compared with those of similar mice 
that did not receive a CRI of lidocaine. Endotoxins 
released during sepsis promote a hyperinflammatory 
state, which activates the coagulation cascade and 
causes adhesion of leukocytes to platelets and endo-
thelium and results in disruption of the microcircu-
latory system and leakage of plasma macromolecules 
into the interstitium.3,12,13 In human patients with 
sepsis, disruption or failure of the microcirculation in 
tissues is correlated with a poor outcome.14 Admin-
istration of lidocaine immediately after endotoxin 
exposure inhibits the production of inflammatory cy-
tokines in horses,4 mice,5 and rabbits.6 Lidocaine sup-
presses in vitro platelet and leukocyte aggregation and 
P-selectin expression, which are sensitive indicators 
of life-threatening thrombotic diseases such as sep-
sis.13 In rats infused with Escherichia coli endotoxin, 
administration of a CRI of lidocaine (33 µg/kg/min) 
decreases the leakage of fluorescein isothiocyanate–
labeled bovine albumin into the peritoneal space.3
Results of other studies7,8 suggest that adminis-
tration of lidocaine to dogs with septicemia does not 
improve systemic vascular resistance or mean arte-
rial pressure, although it does mitigate clinical signs 
of inflammation caused by infection. In the present 
study, the type and rate of IV fluids administered to 
stabilize hemodynamic variables were similar for 
the dogs of both treatment groups, even though the 
number of dogs in group L (dogs that received a CRI 
of lidocaine during surgery) that received an IV bolus 
of a synthetic colloid (1 to 2 mL/kg of 6% hydroxy-
ethyl starch in saline solution) was significantly great-
er than that for group O (dogs that did not receive a 
CRI of lidocaine during surgery). However, the heart 
rate and incidence of hypotension (systolic arterial 
pressure < 90 mm Hg or mean arterial pressure < 60 
mm Hg for > 10 minutes) did not differ significantly 
between the 2 treatment groups during the intraop-
erative period, and the number of synthetic colloid 
boluses administered was not significantly associated 
with the odds of short-term survival after surgery. In 
human patients with severe sepsis, small blood ves-
sel perfusion is a better predictor for survival than 
is mean arterial pressure.14 Consequently, systemic 
hemodynamic variables appear to be only marginally 
correlated with the survival probability of individu-
als with sepsis. The anti-inflammatory properties of 
lidocaine might reduce microcirculatory derange-
ments, thereby improving tissue perfusion and de-
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laying organ dysfunctions, despite less than optimal 
systemic hemodynamic variables.
Of the 54 dogs that were classified as hypotensive 
during the intraoperative period of the present study, 
only 32 (59%) received a vasopressor or inotrope. That 
finding could reflect decisions made by the anesthe-
tists to manage mild to moderate decreases in systolic 
arterial blood pressure by reducing the amount of the 
volatile anesthetic administered or increasing the ad-
ministration rate of IV fluids. Vasopressor or inotropes 
were likely administered only to hypotensive patients 
that failed to respond to changes in the flow rates 
of the volatile anesthetic and IV fluids administered. 
Also, the hemodynamic effects of vasopressors can be 
diminished in some patients with sepsis9; therefore, it 
is possible that some dogs remained hypotensive de-
spite the use of vasopressors.
Volatile anesthetic agents exacerbate hemodynamic 
instability associated with sepsis by decreasing systemic 
vascular resistance in a dose-dependent manner and im-
pairing tissue oxygen extraction.10,15 The intraoperative 
use of opioids as part of a balanced anesthetic protocol 
reduces the requirement for volatile anesthetics.11 How-
ever, opioids cause a dose-dependent, vagally mediated 
bradycardia that is counterbalanced by a baroreceptor-
mediated increase in systemic blood pressure.15 In pa-
tients with sepsis, that counterbalancing mechanism is 
inefficient, which can result in impairment of oxygen 
extraction.15 For the dogs of group L, infusion of lido-
caine in addition to administration of an opioid might 
have helped to decrease the end-tidal concentration of 
isoflurane required to maintain a surgical plane of anes-
thesia, which in turn might have had a positive effect on 
the function of the microcirculatory system.
The final multivariable logistic regression model 
indicated that infusion of lidocaine to dogs during 
the postoperative period had a negative effect on the 
probability of short-term survival. That finding might 
be a result of bias associated with the fairly small 
proportion of dogs (6/33 [18%] dogs in group O and 
15/45 [33%] dogs in group L) that received lidocaine 
during the postoperative period and a type I error.  An-
other plausible explanation for that finding was varia-
tion in the pharmacokinetics of lidocaine for animals 
with varying severity of endotoxemia. The mean plas-
ma concentration of lidocaine was significantly higher 
in rats with experimentally induced sepsis than in 
healthy control rats for up to 2 hours after 1 injection 
of lidocaine (2 mg/kg).16 Unfortunately, the informa-
tion obtained for the present study did not allow us to 
draw any definitive conclusions regarding the mecha-
nism behind the negative association between post-
operative lidocaine infusion and short-term survival.
Limitations of the present study include a fairly 
small study population, the nonrandom nature of li-
docaine administration, and the fact that data for all 
dogs were obtained retrospectively and may have suf-
fered from bias associated with missing information, 
nonuniform record keeping, or operator-dependent 
clinical management. The study population could have 
been increased by including dogs with septic peritoni-
tis that did not undergo surgery; however, we feel that 
including those dogs in the study would have intro-
duced confounding factors and increased bias because 
perioperative variables could not have been assessed 
in all dogs. Therefore, we purposely chose to focus 
only on dogs that underwent laparotomy to identify 
and possibly treat the source of the septic peritonitis.
Another limitation of the present study was the 
lack of a scoring system to classify the severity of the 
sepsis for each dog. To our knowledge, a scoring sys-
tem to classify severity of sepsis has not been validated 
for use in veterinary patients, and the method used to 
diagnose systematic inflammatory response syndrome 
(ie, > 2 of 4 criteria present) is most frequently used 
to evaluate the severity of illness for dogs with septic 
peritonitis.17 Unfortunately, the records for only a few 
dogs of the present study contained sufficient infor-
mation for application of that method. Therefore, we 
decided to use ASA status prior to surgery as a surro-
gate measure of disease severity.
The total amount of lidocaine administered dur-
ing surgery was not standardized for all dogs in group 
L and was dependent on the duration of surgery, 
which ranged from 1 to 3 hours. Thus, amount of li-
docaine administered during surgery might have been 
a confounding factor in this study. To our knowledge, 
studies to evaluate the effect of different infusion 
rates of lidocaine are lacking; however, in a study5 that 
involved mice with experimentally induced septic 
peritonitis, no significant differences were observed 
between mice that received lidocaine at a CRI of 42 
µg/kg/min (19.1 µg/lb/min) and those that received 
lidocaine at a CRI of 83 µg/kg/min (37.7 µg/lb/min).
Results of the present study indicated that a CRI 
of lidocaine (50 µg/kg/min) can be administered in 
conjunction with an opioid as part of a balanced an-
esthesia regimen to improve intraoperative analgesia 
for dogs that underwent surgery for septic peritoni-
tis. Intraoperative infusion of lidocaine might improve 
the short-term survival of dogs with septic peritonitis; 
however, prospective standardized clinical trials are 
necessary to determine the efficacy of lidocaine as a 
supportive treatment for dogs with septic peritonitis.
Footnotes
a. SPSS, version 19, IBM Corp, Chicago, Ill.
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From this month’s AJVR 
Muscle activity and hand motion in veterinarians  
performing laparoscopic training tasks with a box trainer 
Angelo E. Tapia-Araya et al
OBJECTIVE
To evaluate muscle activity and hand motion in veterinarians performing a standard set of laparo-
scopic training tasks.
SAMPLE
12 veterinarians with experience performing laparoscopic procedures.
PROCEDURES
Participants were asked to perform peg transfer, coordination, precision cutting, and suturing tasks in a 
laparoscopic box trainer. Activity of the right biceps brachii, triceps brachii, forearm flexor, forearm exten-
sor, and trapezius muscles was analyzed by means of surface electromyography. Right hand movements 
and wrist angle data were registered through the use of a data glove, and risk levels for the wrist joint 
were determined by use of a modified rapid upper limb assessment (RULA) method. One-way repeated-
measures ANOVA with a Bonferroni post hoc test was performed to compare values between tasks.
RESULTS
Activity in the biceps muscle did not differ significantly among the 4 tasks. Activity in the triceps, forearm 
flexor, and forearm extensor muscles was significantly higher during precision cutting than during the 
coordination task. Activity in the trapezius muscle was highest during the suturing task and did not differ 
significantly among the other 3 tasks. The RULA score was unacceptable (score, 3) for the coordination, 
peg transfer, and precision cutting tasks but was acceptable (score, 2) for the suturing task.
CONCLUSIONS AND CLINICAL RELEVANCE
Results indicated that the ergonomics of laparoscopic training depended on the tasks performed and 
the design of the instruments used. Precision cutting and suturing tasks were associated with the highest 
muscle activity. Acceptable wrist position, as determined with the RULA method, was found with the 
suturing task, which was performed with an axial-handled instrument. (Am J Vet Res 2016;77:186–193) 
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